Chronic Lymphocytic Leukemia Therapeutics Market is Expanding Rapidly as AstraZeneca received the EU Clearance for its CLL Treatment Option Calquence

 

Chronic
lymphocytic leukemia is a cancerous disease in which cancer cells begin to
multiply in the lymph cells. CLL is aggressive cancer that invades the
lymphatic system and attacks healthy cells of the immune system. It typically
affects the lymph nodes and T cells, although it can also affect any other
cells in the human body. The combination of chemotherapy is aimed at destroying
cancer cells while at the same time allowing the body's immune system to
restore the damaged cells. This allows for a more rapid response to the
infection and better overall outcomes. As a result of this combination,
chemotherapy is often used to treat several types of cancer at one time. It has
been very successful in achieving results against most types of cancer. The
targeted drugs are given to make the cancer cells unable to multiply and thus
stop their growth.


Increasing
prevalence of leukemia is expected to drive growth of the global chronic
lymphocytic leukemia therapeutics market during the
forecast period. According to the American Society of Clinical Oncology (ASCO),
chronic lymphocytic leukemia (CLL) is the most common type of leukemia in
adults aged 19 years and above with 37% of cases. According to the same source,
around 21,040 new cases and 4,060 deaths are expected to occur in 2020 due to
CLL in the U.S. Furthermore, according to the Leukemia & Lymphoma Society
(LLC), in 2020, around 60,530 people are expected to be diagnosed with leukemia
in the U.S. Such a high prevalence of CLL and leukemia has increased the demand
for necessary therapeutics such as chemotherapy. Thus, these factors are
expected to drive growth of the global chronic lymphocytic leukemia
therapeutics market during the forecast period. Moreover, increasing geriatric
population is expected to boost the global chronic lymphocytic leukemia
therapeutics market growth over the forecast period.



However,
high cost associated with treatment and stringent regulatory framework is
expected to hinder the global chronic lymphocytic leukemia therapeutics market
growth over the forecast period. Among regions, North America is expected to
witness significant growth in the global chronic lymphocytic leukemia
therapeutics market during the forecast period. This is owing to high incidence
rate of CLL and the presence of key market players such as Amgen Inc., Incyte
Corp, and Pfizer Inc. Furthermore, Asia Pacific is expected to register a
robust growth rate over the forecast period, owing to increasing government
initiatives.



Key players
involved in the global chronic lymphocytic leukemia therapeutics market are
Amgen Inc., Sanofi S.A., AstraZeneca plc, Pfizer Inc., Bristol-Myers Squibb
Company, Novartis International AG, F. Hoffmann-La Roche Ltd, Johnson &
Johnson, and Incyte Corp. 



For
instance, in November 2020, AstraZeneca plc received the European Commission
approval for ‘Calquence’, a next-gen Bruton’s tyrosine kinase (BTK) inhibitor
indicated for adult patients with CLL. 


Comments

  1. FlorenceApril 10, 2021 at 3:46 AM

    I started on COPD Herbal treatment from Ultimate Health Home, the treatment worked incredibly for my lungs condition. I used the herbal treatment for almost 4 months, it reversed my COPD. My severe shortness of breath, dry cough, chest tightness gradually disappeared. Reach Ultimate Health Home via their email at ultimatehealthhome@gmail.com . I can breath much better and It feels comfortable!

    ReplyDelete
  2. meltemJune 27, 2023 at 1:08 AM

    canlı sex hattı
    heets
    https://cfimi.com/
    salt likit
    salt likit
    YRO20

    ReplyDelete

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more